Market Cap 140.84M
Revenue (ttm) 0.00
Net Income (ttm) -27.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 218,800
Avg Vol 280,028
Day's Range N/A - N/A
Shares Out 74.52M
Stochastic %K 97%
Beta 0.90
Analysts Strong Sell
Price Target $8.00

Company Profile

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia....

Industry: Biotechnology
Sector: Healthcare
Phone: (678) 392-3419
Address:
3350 Riverwood Parkway SE, Suite 1900, Atlanta, United States
StockScanners
StockScanners Aug. 23 at 5:47 PM
$IKT keep watch if this holds above 1.73
0 · Reply
TJC1791
TJC1791 Aug. 19 at 9:06 PM
$IKT https://www.inhibikase.com/news/press-releases/detail/133/inhibikase-therapeutics-strengthens-leadership-team-with
2 · Reply
d_risk
d_risk Aug. 17 at 5:23 AM
$IKT - Inhibikase Therapeutics, Inc. - 10Q - Updated Risk Factors IKT flags new risks from potential healthcare cost-cutting laws and U.S. tax changes, plus updates on trade uncertainty and tariffs impacting raw materials despite pharma product exemptions. #Biotechnology #Pharmaceuticals #TradeUncertainty #TaxRisk #HealthcareCosts 🟢 Added 🟠 Removed https://d-risk.ai/IKT/10-Q/2025-08-14
1 · Reply
TJC1791
TJC1791 Aug. 14 at 8:54 PM
$IKT https://www.inhibikase.com/news/press-releases/detail/132/inhibikase-therapeutics-announces-second-quarter2025 PAH trial will start in the “back half”.
0 · Reply
thelingletingle
thelingletingle Aug. 14 at 2:10 PM
$IKT Has this company been abducted by ICE?
1 · Reply
Mjf04288
Mjf04288 Aug. 13 at 2:07 PM
$IKT Earnings today?
1 · Reply
RnJhc2Vy
RnJhc2Vy Aug. 9 at 5:04 AM
$IKT This drop is concerning.
0 · Reply
buffalochips62
buffalochips62 Aug. 8 at 4:17 PM
$IKT I have never seen such a inactive, Stocktwits page. It’s weird. OK well if anyone is listening, are you expecting to hear updates on any catalyst at the ER next week?
2 · Reply
Fib7867
Fib7867 Aug. 7 at 3:15 AM
#myIKTanalysis $IKT
0 · Reply
BillyTheKid62
BillyTheKid62 Aug. 1 at 5:40 PM
$IKT This stock makes my hemmroids bleed faster !
1 · Reply
Latest News on IKT
Inhibikase Announces Expansion of Senior Leadership Team

Feb 24, 2025, 8:00 AM EST - 6 months ago

Inhibikase Announces Expansion of Senior Leadership Team


Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split

Jun 29, 2023, 9:29 AM EDT - 2 years ago

Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split


StockScanners
StockScanners Aug. 23 at 5:47 PM
$IKT keep watch if this holds above 1.73
0 · Reply
TJC1791
TJC1791 Aug. 19 at 9:06 PM
$IKT https://www.inhibikase.com/news/press-releases/detail/133/inhibikase-therapeutics-strengthens-leadership-team-with
2 · Reply
d_risk
d_risk Aug. 17 at 5:23 AM
$IKT - Inhibikase Therapeutics, Inc. - 10Q - Updated Risk Factors IKT flags new risks from potential healthcare cost-cutting laws and U.S. tax changes, plus updates on trade uncertainty and tariffs impacting raw materials despite pharma product exemptions. #Biotechnology #Pharmaceuticals #TradeUncertainty #TaxRisk #HealthcareCosts 🟢 Added 🟠 Removed https://d-risk.ai/IKT/10-Q/2025-08-14
1 · Reply
TJC1791
TJC1791 Aug. 14 at 8:54 PM
$IKT https://www.inhibikase.com/news/press-releases/detail/132/inhibikase-therapeutics-announces-second-quarter2025 PAH trial will start in the “back half”.
0 · Reply
thelingletingle
thelingletingle Aug. 14 at 2:10 PM
$IKT Has this company been abducted by ICE?
1 · Reply
Mjf04288
Mjf04288 Aug. 13 at 2:07 PM
$IKT Earnings today?
1 · Reply
RnJhc2Vy
RnJhc2Vy Aug. 9 at 5:04 AM
$IKT This drop is concerning.
0 · Reply
buffalochips62
buffalochips62 Aug. 8 at 4:17 PM
$IKT I have never seen such a inactive, Stocktwits page. It’s weird. OK well if anyone is listening, are you expecting to hear updates on any catalyst at the ER next week?
2 · Reply
Fib7867
Fib7867 Aug. 7 at 3:15 AM
#myIKTanalysis $IKT
0 · Reply
BillyTheKid62
BillyTheKid62 Aug. 1 at 5:40 PM
$IKT This stock makes my hemmroids bleed faster !
1 · Reply
buffalochips62
buffalochips62 Jul. 31 at 3:10 PM
$IKT seems this is just gonna keep slowly bleeding back to 1. Ugh.
2 · Reply
MB11111
MB11111 Jul. 24 at 2:38 PM
$IKT Ikt is hiring. Clinical trial jobs… https://www.inhibikase.com/careers Careers :: Inhibikase Therapeutics, Inc. (IKT)
1 · Reply
buffalochips62
buffalochips62 Jul. 24 at 1:51 PM
$IKT is the feed to this ticker broken or is it just me? I don’t see any updates in 12 days.?
0 · Reply
Mjf04288
Mjf04288 Jul. 11 at 3:45 PM
$IKT Volume has dried up the past 2 days. Company needs to provide some updates
1 · Reply
buffalochips62
buffalochips62 Jul. 10 at 6:16 PM
$IKT is this dead money for a while or are catalysts coming up in the next couple quarters? Thanks
2 · Reply
Finanz
Finanz Jul. 5 at 8:03 PM
$IKT Time for a short squeeze?
0 · Reply
TJC1791
TJC1791 Jun. 30 at 10:20 PM
$IKT https://www.ainvest.com/news/inhibikase-therapeutics-russell-2500-inclusion-strategic-pivot-small-cap-biotech-investors-parkinson-pipeline-shifts-2507/
1 · Reply
TJC1791
TJC1791 Jun. 28 at 4:31 PM
$IKT @PharmToBank how you feeling about this recent imatinib trial that seems to be well tolerated? Any concerns on the viability of IKT pro?
1 · Reply
Mjf04288
Mjf04288 Jun. 28 at 2:05 AM
$IKT What is going on? After hours volume 7.06 million
1 · Reply
stockanalysis_
stockanalysis_ Jun. 27 at 9:48 PM
After Hours Losers: $SERA $ODYS $AMIX $INTG $IKT View the entire list here: https://stockanalysis.com/markets/afterhours/?ref=saveontrading
0 · Reply
WillisMcGillis
WillisMcGillis Jun. 26 at 8:06 PM
$IKT Phase 3 Risvo https://www.globenewswire.com/news-release/2025/05/21/3085719/0/en/ABLi-Therapeutics-Announces-Details-of-the-End-of-Phase-2-Meeting-with-FDA-for-Evaluation-of-Risvodetinib-as-a-Treatment-for-Parkinson-s-Disease.html
2 · Reply
Major_Bagholder
Major_Bagholder Jun. 21 at 6:08 PM
$IKT How does the share price not immediately drop below a $1 with this filing?
2 · Reply